Centre for Medicines Research International Limited
Registered name: CENTRE FOR MEDICINES RESEARCH INTERNATIONAL LIMITED
Part of Clarivate Plc groupCentre for Medicines Research International Limited made £0 revenue and £8.8m profit in the year to 31 Dec 2024.
Centre for Medicines Research International Limited’s revenue fell 100% to £0 in the year to 31 Dec 2024, with £8.8m profit and 0 employees. The company is classified under “dormant company” and is based in London; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- London
- Age
- 25 yrs · since 2001
- Type
- Private Limited Company
Key figures
Unusual figures. Profit is higher than revenue in this filing. That usually means investment income, dividends from subsidiaries or one-off gains — or a mis-tagged figure. Check the original filing before drawing conclusions.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 |
|---|---|---|
| Disclosure | Profit & loss | Profit & loss |
| Profit & loss | ||
| Revenue (turnover) | £5.1m | £0 |
| Operating profit | £2.6m | £0 |
| Profit before tax | £3.2m | £8.8m |
| Profit after tax | £3.2m | £8.8m |
| Profit (best available) | £3.2m | £8.8m |
| Employees (average) | 12 | 0 |
| Ratios | ||
| Profit margin | 62.4% | — |
| Revenue per employee | £428k | — |
| Profit per employee | £267k | — |
| Growth (year on year) | ||
| Revenue growth | — | ▼100% |
| Profit growth | — | ▲173.8% |
| Headcount growth | — | ▼100% |
| Balance sheet — indirect signals, not revenue | ||
| Net assets | — | — |
| Source | Accounts · bulk data Oct 2025 | Accounts · bulk data Oct 2025 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- ▼100%
- Now 0
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Clarivate Plc (registered outside the UK register)ultimate parent75–100%
- Camelot UK Top Holdco Limited75–100%
- Camelot UK Holdco Limited75–100%
- Camelot UK Bidco Limited75–100%
- Clarivate Analytics (UK) Limited75–100%
- Centre for Medicines Research International Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (2)
- Centre for Innovation in Regulatory Science LimitedFigures not disclosed
- Sigmatic LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from accounts for the year to 31 Dec 2024 (profit £8.8m), from the Companies House accounts bulk data published Oct 2025. Spotted an error? Request a correction.
Updated from Companies House on 18 Oct 2026